Plasma concentrations, pharmacokinetics and urinary excretion of gatifloxacin after single intravenous injection in buffalo calves

Veterinary Research Communications

Volumn 31, Issue 8, 2007, Pages 1013-1020

  Raipuria, M ^a   Dumka, V K ^a   Sandhu, Harpal S ^a  

^a PUNJAB AGRICULTURAL UNIVERSITY   (India)

Author keywords

Buffalo calves; Dosage; Gatifloxacin; Pharmacokinetics

Indexed keywords

GATIFLOXACIN; GATIQUIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BUFFALO; DISTRIBUTION VOLUME; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG TISSUE LEVEL; MALE; NONHUMAN; SINGLE DRUG DOSE; URINARY EXCRETION;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BUFFALOES; FLUOROQUINOLONES; HALF-LIFE; INJECTIONS, INTRAVENOUS; MALE;

EID: 34447258639     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-007-3343-7     Document Type: Article

References (24)

1. Andes, D. and Craig, W.A., 2002. Pharmacodynamics of the new fluoroquinolone gatifloxacin in murine thigh and lung infection models. Antimicrobial Agents and Chemotherapy, 46(6), 1665-1670
2. Arret, B., Johnson, D.P. and Krishbaum, A., 1971. Outline of details for microbiological assay of antibiotics: Second revision. Journal of Pharmaceutical Science, 60, 1689-1694
3. Bakken, J.S., 2004. The fluoroquinolones: How long will their utility last? Scandinavian Journal of Infectious Diseases, 36(2), 85-92
4. Bauernfeind, A., 1997. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM-1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. Journal of Antimicrobial Chemotherapy, 440, 639-651
5. Esel, D., Doganay, M. and Sumerkan, B., 2003. Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey. International Journal of Antimicrobial Agents, 22(1), 70-72
6. Fish, D.N. and North, D.S., 2001. Gatifloxacin, an advanced 8-methoxy fluoroquinolone. Pharmacotherapy, 21(1), 35-59
7. Gajjar, D.A., LaCreta, F.P. and Uderman, H.D., 2000. A dose-escalation study of the safety, tolerability and pharmacokinetics of intravenous gatifloxacin in healthy adult men. Pharmacotherapy, 20 (6), 49S-58
8. Gibaldi, M. and Perrier, D., 1982. Methods of residuals. Pharmacokinetics, 2nd edn, (Marcel Dekker, New York), 433-444
9. Grasela, D.M., Christofalo, B., LaCreto, F.P., Kollia, G.D., Duncan, G. and Noveck, R., 1998. Single-dose safety and pharmacokinetics of oral gatifloxacin in subjects in subjects with hepatic impairment. Program and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego
10. LaCreta, F.P., Kaul, S., Kollia, G.D., Duncan, G., Randall, D.M. and Grasela, D.M., 2000a. Interchangebility of 400, mg intravenous and oral gatifloxacin in healthy adults. Pharmacotherapy, 20 (6), 59S-66
11. LaCreta, F.P., Kollia, G.D., Duncan, G., Behr, D. and Grasela, D.M., 2000b. Age and gender effects on the pharmacokinetics of gatifloxacin. Pharmacotherapy, 20 (6), 67S-75
12. Lutsar, I., Friedland, I.R., Wubbel, L., McCoig, C.C., Jafri, H.S., Ng, W., Ghaffar, F and McCracken, G.H. Jr., 1998. Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy, 42 (10), 2650-2655
13. Mckellar, Q.A., Sanchez Bruni, S.F. and Jones, D.G., 2004. Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics, 27(6), 503-514
14. Moutafchieva, R. and Djouvinov, D., 1997. Pharmacokinetics of pefloxacin in sheep. Journal of Veterinary Pharmacology and Therapeutics, 20, 405-407
15. Naber, C.K., Steghafner, M. and Kinzig-Schippers, M., 2001. Concentration of gatifloxacin in plasma and urine and penetration into prostatic and seminal fluid, ejaculate and sperm cells after single oral administration of 400 milligrams to volunteers. Antimicrobial Agents and Chemotherapy, 45, 293-297
16. Nakashima, M., Uemastu, T., Kosuge, K., Kusajima, H., Ooie, T., Masuda, Y., Ishida, R. and Uchida, H., 1995. Single and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone in humans. Antimicrobial Agents and Chemotherapy, 39, 2635-2640
17. Nawaz, M., Khan, H. and Rahman, Z., 1980. Pharmacokinetics of sulfadimidine in ruminants. Proceedings of the First International Congress of Veterinary Pharmacology, Cambridge, UK, 57-63
18. Perry, C.M., Ormrod, D., Hurst, M. and Onrust, S.V., 2002. Gatifloxacin: a review of its use in the management of bacterial infectins. Drugs, 62(1), 169-207
19. Raina, R., 1993. Pharmacokinetic and toxicological studies of ciprofloxacin in buffalo calves, goats and poultry, (PhD. dissertation, CCS Haryana Agricultural University, Hisar, India)
20. Rodvold, K.A. and Neuhauser, M., 2001. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Pharmacotherapy, 21(105), 233-252
21. Singh, K. and Srivastava, A.K., 2000. Pharmacokinetics and urinary excretion of ciprofloxacin in cross bred cow calves. Indian Journal of Animal Sciences, 70(10), 1021-1024
22. Stahlberg, H.J., Goehler, K., Guillaume, M. and Mignot, A., 1998. Pharmacokinetics of R- and S-enantiomers of gatifloxacin, a new fluoroquinolone antibiotic, following single oral doses to healthy caucasian volunteers. Program and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego
23. Thomas, V., Deleforge, J. and Boisrame, B., 1994. Pharmacokinetics of marbofloxacin in pre-ruminant and ruminant cattle. Proceedings of the 6th Congress of European Association for Veterinary Pharmacology and Toxicology, Edinburgh, Scotland, 60-61
24. Zinner, S.H., Firsov, A.A., Gilbert, D., Simmons, K. and Lubenko, I.Y., 2001. The pharmacodynamics of gatifloxacin and ciprofloxacin for peneumococci in an in vitro dynamic model: Prediction of equiefficient doses. Journal of Antimicrobial Chemotherapy, 48(6), 821-826